awmsg logo



magnesium aspartate dihydrate (Magnaspartate)


Reference No. 2596

Publication date:
02/09/2015


Appraisal information

magnesium aspartate dihydrate (Magnaspartate) 243 mg powder for oral solution


Company: Kora Corporation Ltd trading as Kora Healthcare
BNF category: Nutrition and blood
NMG meeting date: 10/06/2015
AWMSG meeting date: 15/07/2015
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 2215
Ministerial ratification: 27/08/2015

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Magnesium aspartate dihydrate (Magnaspartate®) is recommended as an option for use within NHS Wales for the treatment and prevention of magnesium deficiency, as diagnosed by a doctor, in adults, children and adolescents aged from two years.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download